Evidence map›Paper›PMID 34724560›Full record

ArticleBioscience reports2021

In vivo therapeutic exploring for Mori folium extract against type 2 diabetes mellitus in rats.

Kaibo Lyu, Wei Yue, Junhua Ran, Yunjuan Liu, Xueliang Zhu

Open access · goldAbstract read
In one paragraph

Article in Bioscience reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Metabolomics Analysis of the Mechanism of Yuquan Capsules in the Treatment of T2DM Rats Using UPLC/MS.Diabetes, metabolic syndrome and obesity : targets and therapy · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Kaibo LyuCollege of Environmental and Biological Engineering, Wuhan Technology and Business University, Wuhan 430065, Hubei, P.R. China.
Wei YueCollege of Environmental and Biological Engineering, Wuhan Technology and Business University, Wuhan 430065, Hubei, P.R. China.
Junhua RanDepartment of Nutrition, The First Affiliated Hospital of Xinxiang Medical University, Weihui 453100, Henan, P.R. China.
Yunjuan LiuI Faithfood Technology (Beijing) Co., Ltd, Beijing 100007, P.R. China.
Xueliang ZhuState Key Laboratory of Advanced Technology for Materials Synthesis and Processing, Wuhan University of Technology, Wuhan, Hubei 430070, P.R. China.ORCID 0000-0003-2148-3905
Wuhan Technology and Business University · CNFirst Affiliated Hospital of Xinxiang Medical University · CNWuhan University of Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe study was aimed to investigate the potential therapeutic effect of Mori folium aqueous extracts (MFAE) on type 2 diabetes mellitus (T2DM) in vivo. METHODS AND

resultsA rat model of T2DM was established with the combination of high sugar and high-fat diet (HSFD) and streptozotocin (STZ). The T2DM rats were administrated with low (2 g.kg-1) and high (5 g.kg-1) doses of MFAE for 60 consecutive days. The biochemical indices of glucose metabolism disorders, insulin resistance and oxidative stress were observed. The results indicated that MFAE significantly promoted the synthesis of hepatic glycogen, reduced the levels of fasting blood glucose and fasting blood insulin, and improved the insulin sensitivity index (ISI). MFAE administration also remarkably increased the levels of superoxide dismutase (SOD) and reduced the levels of malondialdehyde (MDA).

conclusionMFAE showed a therapeutic effect on T2DM with the bioative effect of improve glucose metabolism disorders, decrease insulin resistance, and ameliorate the antioxidative ability.

Indexed as

MorusAnimalsBiomarkersBlood GlucoseDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 2Hypoglycemic AgentsInsulinInsulin ResistanceMaleMalondialdehydeOxidative StressPancreasPlant ExtractsPlant LeavesRatsBiomarkersBlood GlucoseHypoglycemic AgentsInsulinMalondialdehydePlant ExtractsSuperoxide Dismutaseglucose metabolisminsulin resistanceMori folium aqueous extractoxidative stresstype 2 diabetes mellitus

Identifiers

PMID34724560
PMCPMC8661501
OpenAlexW3211006267

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.